The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 04, 2022

Filed:

Jul. 13, 2018
Applicant:

Fudan University, Shanghai, CN;

Inventors:

Gang Wei, Shanghai, CN;

Kuan Jiang, Shanghai, CN;

Weiyue Lu, Shanghai, CN;

Chang Liu, Shanghai, CN;

Lingyu Tai, Shanghai, CN;

Xin Gao, Shanghai, CN;

Assignee:

FUDAN UNIVERSITY, Shanghai, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/64 (2017.01); C07K 7/08 (2006.01); A61K 47/54 (2017.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 9/0048 (2013.01); A61K 47/545 (2017.08); A61K 47/549 (2017.08); C07K 7/08 (2013.01);
Abstract

The present disclosure belongs to the field of pharmaceutical preparations and relates to the design of a series of lipophilic derivatives by using wild-type penetrating peptide penetratin. These penetratin derivatives have a strong ability to penetrate the ocular tissues and do not cause ocular tissue toxicity. As ocular absorption enhancers, non-invasive routes could be used to achieve intraocular drug delivery and increase the ocular bioavailability of drugs. These penetratin derivatives and the ophthalmic drug delivery system constructed by them are used for eye drop administration, which could replace the intraocular injection with poor patients compliance, which greatly enhances the convenience and safety of the treatment of intraocular and fundus diseases.


Find Patent Forward Citations

Loading…